We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-12.06%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$64.6M
AUM Growth
-$12M
Cap. Flow
+$1.13M
Cap. Flow %
1.75%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
IMA
ImageneBio Inc
IMA
+$1.13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$25.4M 39.38%
3,931,818
DYN icon
2
Dyne Therapeutics
DYN
$4.24B
$19.9M 30.79%
2,220,034
ALLO icon
3
Allogene Therapeutics
ALLO
$604M
$5.7M 8.82%
1,798,163
KRON
4
DELISTED
Kronos Bio
KRON
$3.59M 5.56%
2,765,314
LIAN
5
DELISTED
LianBio American Depositary Shares
LIAN
$3.4M 5.26%
2,282,084
KNTE
6
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.09M 4.78%
2,207,772
PRAX icon
7
Praxis Precision Medicines
PRAX
$8.8B
$2.51M 3.89%
97,978
IMA
8
ImageneBio Inc
IMA
$63.2M
$975K 1.51%
+18,766
New +$1.13M

Similar funds

Vida Ventures Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Vida Ventures Advisors held 8 positions worth $64.6M, down 16% from $76.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors's Q3 2023 filing shows 1 new position. Its largest new stake was ImageneBio Inc: 18,766 shares worth $975K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's largest Q3 2023 buy was ImageneBio Inc: 18,766 shares worth $975K.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $64.6M portfolio in Q3 2023.
  • Vida Ventures Advisors opened 1 new position and closed 0 in Q3 2023.
  • Vida Ventures Advisors's portfolio value fell 16% quarter-over-quarter to $64.6M.

Based on Vida Ventures Advisors's 13F filing for Q3 2023, filed 3 Oct 2023.